Hyperinsulinaemia: A prospective risk factor for lethal clinical prostate cancer
- 1 December 2005
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 41 (18), 2887-2895
- https://doi.org/10.1016/j.ejca.2005.09.003
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Prostate cancer: another aspect of the insulin‐resistance syndrome?Obesity Reviews, 2002
- Leptin Is Associated with Increased Prostate Cancer Risk: A Nested Case-Referent StudyJournal of Clinical Endocrinology & Metabolism, 2001
- Hormones and Prostate Cancer: What's Next?Epidemiologic Reviews, 2001
- Clinical, Anthropometric, Metabolic and Insulin Profile of Men with Fast Annual Growth Rates of Benign Prostatic HyperplasiaBlood Pressure, 1999
- Components of the metabolic syndrome—risk factors for the development of benign prostatic hyperplasiaProstate Cancer and Prostatic Diseases, 1998
- Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemiaJournal of Internal Medicine, 1993
- The TNM classification of prostate cancerThe Prostate, 1992
- Banting lecture 1988. Role of insulin resistance in human diseaseDiabetes, 1988
- Effects of massive obesity on insulin sensitivity and insulin clearance and the metabolic response to insulin as assessed by the euglycemic clamp techniqueMetabolism, 1986
- Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.Journal of Clinical Investigation, 1980